{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T07:02:38Z","timestamp":1791874958673,"version":"4.3.4"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Hypertens Rep"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1007\/s11906-018-0804-z","type":"journal-article","created":{"date-parts":[[2018,1,22]],"date-time":"2018-01-22T08:14:36Z","timestamp":1516608876000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":73,"title":["Pheochromocytomas and Hypertension"],"prefix":"10.1007","volume":"20","author":[{"given":"Joseph M.","family":"Pappachan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nyo Nyo","family":"Tun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganesan","family":"Arunagirinathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravinder","family":"Sodi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahmy W. F.","family":"Hanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,1,22]]},"reference":[{"key":"804_CR1","doi-asserted-by":"crossref","unstructured":"\u2022\u2022 Lenders JW, Duh QY, Eisenhofer G, Gimenez-Roqueplo AP, Grebe SK, Murad MH, et al. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2014; 99:1915-42. Current clinical practice guidelines (2014) by the American Endocrine Society that give readers clear idea how to approach cases with PPGLs. Readers are strongly recommended to read this free paper in the journal for thorough understanding of the clinical problem.","DOI":"10.1210\/jc.2014-1498"},{"key":"804_CR2","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1007\/s11906-014-0442-z","volume":"16","author":"JM Pappachan","year":"2014","unstructured":"\u2022 Pappachan JM, Raskauskiene D, Sriraman R, Edavalath M, Hanna FW. Diagnosis and management of pheochromocytoma: a practical guide to clinicians. Curr Hypertens Rep. 2014;16:442. A 2014 review in Current Hypertension Reports discussing the practical aspects of diagnostic and therapeutic approaches to PPGLs.","journal-title":"Curr Hypertens Rep"},{"issue":"3","key":"804_CR3","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1111\/j.1464-410X.2007.07370.x","volume":"101","author":"C Andreoni","year":"2008","unstructured":"Andreoni C, Krebs RK, Bruna PC, Goldman SM, Kater CE, Alves MT, et al. Cystic phaeochromocytoma is a distinctive subgroup with special clinical, imaging and histological features that might mislead the diagnosis. BJU Int. 2008;101(3):345\u201350. https:\/\/doi.org\/10.1111\/j.1464-410X.2007.07370.x .","journal-title":"BJU Int"},{"key":"804_CR4","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/5584_2016_26","volume":"956","author":"JM Pappachan","year":"2017","unstructured":"\u2022 Pappachan JM, Buch HN. Endocrine hypertension: a practical approach. Adv Exp Med Biol. 2017;956:215\u201337. A book chapter on approach to the practical aspects of endocrine hypertension. The chapter gives brief discussion on PPGLs also.","journal-title":"Adv Exp Med Biol"},{"key":"804_CR5","first-page":"8295010","volume":"2017","author":"L Wang","year":"2017","unstructured":"Wang L, Li N, Yao X, Chang G, Zhang D, Heizhati M, et al. Detection of secondary causes and coexisting diseases in hypertensive patients: OSA and PA are the common causes associated with hypertension. Biomed Res Int. 2017;2017:8295010.","journal-title":"Biomed Res Int"},{"key":"804_CR6","doi-asserted-by":"crossref","unstructured":"Verberne AJ, Korim WS, Sabetghadam A, Llewellyn-Smith IJ. Adrenaline: insights into its metabolic roles in hypoglycaemia and diabetes. Br J Pharmacol. 2016;173:1425\u201337.","DOI":"10.1111\/bph.13458"},{"issue":"8","key":"804_CR7","doi-asserted-by":"publisher","first-page":"3157","DOI":"10.1210\/en.2016-1108","volume":"157","author":"T Wiedemann","year":"2016","unstructured":"Wiedemann T, Peitzsch M, Qin N, Neff F, Ehrhart-Bornstein M, Eisenhofer G, et al. Morphology, biochemistry, and pathophysiology of MENX-related pheochromocytoma recapitulate the clinical features. Endocrinology. 2016;157(8):3157\u201366. https:\/\/doi.org\/10.1210\/en.2016-1108 .","journal-title":"Endocrinology"},{"issue":"2","key":"804_CR8","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nrc3648","volume":"14","author":"PL Dahia","year":"2014","unstructured":"Dahia PL. Pheochromocytoma and paraganglioma pathogenesis: learning from genetic heterogeneity. Nat Rev Cancer. 2014;14(2):108\u201319. https:\/\/doi.org\/10.1038\/nrc3648 .","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"804_CR9","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nrendo.2014.188","volume":"11","author":"J Favier","year":"2015","unstructured":"Favier J, Amar L, Gimenez-Roqueplo AP. Paraganglioma and phaeochromocytoma: from genetics to personalized medicine. Nat Rev Endocrinol. 2015;11(2):101\u201311. https:\/\/doi.org\/10.1038\/nrendo.2014.188 .","journal-title":"Nat Rev Endocrinol"},{"key":"804_CR10","doi-asserted-by":"crossref","first-page":"R239","DOI":"10.1530\/ERC-16-0542","volume":"24","author":"A Angelousi","year":"2017","unstructured":"Angelousi A, Dimitriadis GK, Zografos G, N\u00f6lting S, Kaltsas G, Grossman A. Molecular targeted therapies in adrenal, pituitary and parathyroid malignancies. Endocr Relat Cancer. 2017;24:R239\u201359.","journal-title":"Endocr Relat Cancer"},{"issue":"3","key":"804_CR11","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1210\/jc.2010-1946","volume":"96","author":"M Ayala-Ramirez","year":"2011","unstructured":"Ayala-Ramirez M, Feng L, Johnson MM, Ejaz S, Habra MA, Rich T, et al. Clinical risk factors for malignancy and overall survival in patients with pheochromocytomas and sympathetic paragangliomas: primary tumor size and primary tumor location as prognostic indicators. J Clin EndocrinolMetab. 2011;96(3):717\u201325. https:\/\/doi.org\/10.1210\/jc.2010-1946 .","journal-title":"J Clin EndocrinolMetab"},{"key":"804_CR12","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s40200-016-0226-x","volume":"15","author":"A Soltani","year":"2016","unstructured":"\u2022\u2022 Soltani A, Pourian M, Davani BM. Does this patient have pheochromocytoma? A systematic review of clinical signs and symptoms. J Diabetes Metab Disord. 2016;15:6. A very useful systematic review detailing the clinical features of PPGLs. Readers are strongly recommended to use this paper for better understanding of the symptomatology and pathophysiology of PPGLs.","journal-title":"J Diabetes Metab Disord"},{"key":"804_CR13","doi-asserted-by":"crossref","first-page":"3296","DOI":"10.1210\/jc.2017-00992","volume":"102","author":"O Hamidi","year":"2017","unstructured":"\u2022 Hamidi O, Young WF Jr, I\u00f1iguez-Ariza NM, et al. Malignant pheochromocytoma and paraganglioma: 272 patients over 55 years. J Clin Endocrinol Metab. 2017;102:3296\u2013305. A useful paper to get better understanding about the characteristics of malignant PPGLs and their epidemiology.","journal-title":"J Clin Endocrinol Metab"},{"key":"804_CR14","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1056\/NEJMimc0806409","volume":"361","author":"JJ Ross","year":"2009","unstructured":"\u2022\u2022 Ross JJ, Desai AS, Chutkow WA, Economy KE, Dec GW Jr. Interactive medical case. A crisis in late pregnancy. N Engl J Med. 2009;361:e45. An interactive medical case with a lot of multi-media learning material that gives readers excellent understanding of the pathophysiology and clinical features of PPGLs.","journal-title":"N Engl J Med"},{"key":"804_CR15","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1210\/jc.2015-3889","volume":"101","author":"A Flynn","year":"2016","unstructured":"\u2022\u2022 Flynn A, Dwight T, Harris J, et al. Pheo-type: a diagnostic gene-expression assay for the classification of pheochromocytoma and paraganglioma. J Clin Endocrinol Metab. 2016;101:1034\u201343. A paper that discusses the latest genetic aspects of PPGLs.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3-4","key":"804_CR16","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1159\/000457479","volume":"150","author":"D Amorim-Pires","year":"2016","unstructured":"Amorim-Pires D, Peixoto J, Lima J. Hypoxia pathway mutations in pheochromocytomas and paragangliomas. Cytogenet Genome Res. 2016;150(3-4):227\u201341. https:\/\/doi.org\/10.1159\/000457479 .","journal-title":"Cytogenet Genome Res"},{"issue":"12","key":"804_CR17","doi-asserted-by":"publisher","first-page":"4764","DOI":"10.1210\/jc.2016-2103","volume":"101","author":"LJ Castro-Vega","year":"2016","unstructured":"Castro-Vega LJ, Kiando SR, Burnichon N, Buffet A, Amar L, Simian C, et al. The MITF, p. E318K variant, as a risk factor for pheochromocytoma and paraganglioma. J Clin Endocrinol Metab. 2016;101(12):4764\u20138. https:\/\/doi.org\/10.1210\/jc.2016-2103 .","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"804_CR18","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1210\/jc.2015-2948","volume":"101","author":"S Latteyer","year":"2016","unstructured":"Latteyer S, Klein-Hitpass L, Khandanpour C, Zwanziger D, Poeppel TD, Schmid KW, et al. A 6-base pair in frame germline deletion in exon 7 of RET leads to increased RET phosphorylation, ERK activation, and MEN2A. J Clin Endocrinol Metab. 2016;101(3):1016\u201322. https:\/\/doi.org\/10.1210\/jc.2015-2948 .","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"804_CR19","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.surg.2016.05.059","volume":"161","author":"B Babic","year":"2017","unstructured":"Babic B, Patel D, Aufforth R, Assadipour Y, Sadowski SM, Quezado M, et al. Pediatric patients with pheochromocytoma and paraganglioma should have routine preoperative genetic testing for common susceptibility genes in addition to imaging to detect extra-adrenal and metastatic tumors. Surgery. 2017;161(1):220\u20137. https:\/\/doi.org\/10.1016\/j.surg.2016.05.059 .","journal-title":"Surgery"},{"issue":"1","key":"804_CR20","doi-asserted-by":"publisher","first-page":"R9","DOI":"10.1530\/EJE-15-0549","volume":"174","author":"F Castinetti","year":"2016","unstructured":"Castinetti F, Taieb D, Henry JF, Walz M, Guerin C, Brue T, et al. Management of endocrine disease: outcome of adrenal sparing surgery in heritable pheochromocytoma. Eur J Endocrinol. 2016;174(1):R9\u2013R18. https:\/\/doi.org\/10.1530\/EJE-15-0549 .","journal-title":"Eur J Endocrinol"},{"key":"804_CR21","doi-asserted-by":"publisher","unstructured":"Bj\u00f6rklund P, Backman S. Epigenetics of pheochromocytoma and paraganglioma. Mol Cell Endocrinol. 2017; https:\/\/doi.org\/10.1016\/j.mce.2017.06.016 .","DOI":"10.1016\/j.mce.2017.06.016"},{"key":"804_CR22","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1056\/NEJMcps0708258","volume":"361","author":"AS Desai","year":"2009","unstructured":"\u2022\u2022 Desai AS, Chutkow WA, Edelman E, Economy KE, Dec GW Jr. Clinical problem-solving. A crisis in latepregnancy. N Engl J Med. 2009;361:2271\u20137. An excellent write-up based on a case study that gives details of pathophysiology of catecholaminergic cardiomyopathy in PPGLs. The article also provides basic insights into the clinical aspects and management of PPGLs.","journal-title":"N Engl J Med"},{"issue":"36","key":"804_CR23","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000004846","volume":"95","author":"Y-L Chiang","year":"2016","unstructured":"Chiang Y-L, Chen P-C, Lee C-C, Chua S-K. Adrenal pheochromocytoma presenting with Takotsubo-pattern cardiomyopathy and acute heart failure: a case report and literature review. Medicine (Baltimore). 2016;95(36):e4846. https:\/\/doi.org\/10.1097\/MD.0000000000004846 .","journal-title":"Medicine (Baltimore)"},{"key":"804_CR24","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1016\/j.amjcard.2016.03.019","volume":"117","author":"Y Shams","year":"2016","unstructured":"Shams Y. Clinical features and outcome of pheochromocytoma-induced Takotsubo syndrome: analysis of 80 published cases. Am J Cardiol. 2016;117:1836\u201344.","journal-title":"Am J Cardiol"},{"key":"804_CR25","doi-asserted-by":"crossref","first-page":"e2198","DOI":"10.1097\/MD.0000000000002198","volume":"94","author":"M Batisse-Lignier","year":"2015","unstructured":"\u2022 Batisse-Lignier M, Pereira B, Motreff P, et al. Acute and chronic pheochromocytoma-induced cardiomyopathies: different prognoses?: a systematic analytical review. Medicine (Baltimore). 2015;94:e2198. An important paper that details cardiomyopathy related to PPGLs.","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"804_CR26","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s12020-017-1300-y","volume":"56","author":"R D\u00e4rr","year":"2017","unstructured":"D\u00e4rr R, Kuhn M, Bode C, Bornstein SR, Pacak K, Lenders JWM, et al. Accuracy of recommended sampling and assay methods for the determination of plasma-free and urinary fractionated metanephrines in the diagnosis of pheochromocytoma and paraganglioma: a systematic review. Endocrine. 2017;56(3):495\u2013503. https:\/\/doi.org\/10.1007\/s12020-017-1300-y .","journal-title":"Endocrine"},{"key":"804_CR27","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.4158\/EP171877.OR","volume":"23","author":"Y Chen","year":"2017","unstructured":"\u2022 Chen Y, Xiao H, Zhou X, Huang X, Li Y, Xiao H, et al. Accuracy of plasma free metanephrines in the diagnosis of pheochromocytoma and paraganglioma: a systematic review and meta-analysis. Endocr Pract. 2017;23:1169\u201377. A systematic review that looks at the diagnostic test accuracy of biochemical aspects of PPGL diagnosis.","journal-title":"Endocr Pract"},{"issue":"2","key":"804_CR28","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1530\/EJE-17-0077","volume":"177","author":"D Rao","year":"2017","unstructured":"Rao D, Peitzsch M, Prejbisz A, Hanus K, Fassnacht M, Beuschlein F, et al. Plasma methoxytyramine: clinical utility with metanephrines for diagnosis of pheochromocytoma and paraganglioma. Eur J Endocrinol. 2017;177(2):103\u201313. https:\/\/doi.org\/10.1530\/EJE-17-0077 .","journal-title":"Eur J Endocrinol"},{"key":"804_CR29","doi-asserted-by":"crossref","first-page":"R109","DOI":"10.1530\/EJE-13-0882","volume":"170","author":"A Berkel van","year":"2014","unstructured":"\u2022\u2022 van Berkel A, Lenders JW, Timmers HJ. Diagnosis of endocrine disease: biochemical diagnosis of phaeochromocytoma and paraganglioma. Eur J Endocrinol. 2014;170:R109\u201319. A very useful paper examining the practical aspects of biochemical diagnosis of PPGLs. The article also provide readers insights into the testing algorithm when tests are just borderline positive.","journal-title":"Eur J Endocrinol"},{"key":"804_CR30","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-16-0033","volume":"174","author":"PF Plouin","year":"2016","unstructured":"\u2022\u2022 Plouin PF, Amar L, Dekkers OM, et al. European Society of Endocrinology Clinical Practice Guideline for long-term follow-up of patients operated on for a phaeochromocytoma or a paraganglioma. Eur J Endocrinol. 2016;174:G1\u2013G10. The paper with most recent European Society guidelines on PPGL care and follow-up. Readers are strongly recommended to review this paper to get better understanding about the practical aspects of care of patients with PPGLs.","journal-title":"Eur J Endocrinol"},{"key":"804_CR31","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1210\/jc.2009-0303","volume":"94","author":"WH Jong de","year":"2009","unstructured":"de Jong WH, Eisenhofer G, Post WJ, Muskiet FA, de Vries EG, Kema IP. Dietary influences on plasma and urinary metanephrines: implications for diagnosis of catecholamine-producing tumors. J Clin EndocrinolMetab. 2009;94:2841\u20139.","journal-title":"J Clin EndocrinolMetab"},{"key":"804_CR32","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/eci.12245","volume":"44","author":"S Zuber","year":"2014","unstructured":"Zuber S, Wesley R, Prodanov T, Eisenhofer G, Pacak K, Kantorovich V. Clinical utility of chromogranin A in SDHx-related paragangliomas. Eur J Clin Invest. 2014;44:365\u201371.","journal-title":"Eur J Clin Invest"},{"issue":"Supplementum 3","key":"804_CR33","doi-asserted-by":"crossref","first-page":"S397","DOI":"10.33549\/physiolres.933719","volume":"66","author":"R B\u00edlek","year":"2017","unstructured":"B\u00edlek R, Zelinka T, Vl\u010dek P, Du\u0161kov\u00e1 J, et al. Radioimmunoassay of chromogranin A and free metanephrines in diagnosis of pheochromocytoma. Physiol Res. 2017;66(Supplementum 3):S397\u2013408.","journal-title":"Physiol Res"},{"key":"804_CR34","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1210\/jc.2002-030005","volume":"88","author":"G Eisenhofer","year":"2003","unstructured":"\u2022 Eisenhofer G, Goldstein DS, Walther MM, Friberg P, Lenders JW, Keiser HR, et al. Biochemical diagnosis of pheochromocytoma: how to distinguish true- from false-positive test results. J Clin Endocrinol Metab. 2003;88:2656\u201366. A study that gives practical tips to predictive values and interpretation of biochemical tests in PPGLs.","journal-title":"J Clin Endocrinol Metab"},{"key":"804_CR35","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1530\/EJE-09-0996","volume":"162","author":"E Grouzmann","year":"2010","unstructured":"\u2022 Grouzmann E, Drouard-Troalen L, Baudin E, Plouin PF, Muller B, Grand D, et al. Diagnostic accuracy of free and total metanephrines in plasma and fractionated metanephrines in urine of patients with pheochromocytoma. Eur J Endocrinol. 2010;162:951\u201360. Another study that gives practical tips to predictive values and interpretation of biochemical tests in PPGLs.","journal-title":"Eur J Endocrinol"},{"issue":"45","key":"804_CR36","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000001948","volume":"94","author":"JH Jun","year":"2015","unstructured":"Jun JH, Ahn HJ, Lee SM, Kim JA, Park BK, Kim JS, et al. Is preoperative biochemical testing for pheochromocytoma necessary for all adrenal incidentalomas? Medicine (Baltimore). 2015;94(45):e1948. https:\/\/doi.org\/10.1097\/MD.0000000000001948 .","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"804_CR37","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.2214\/AJR.15.15318","volume":"206","author":"N Schieda","year":"2016","unstructured":"Schieda N, Alrashed A, Flood TA, Samji K, Shabana W, McInnes MD. Comparison of quantitative MRI and CT washout analysis for differentiation of adrenal pheochromocytoma from adrenal adenoma. Am J Roentgenol. 2016;206(6):1141\u20138. https:\/\/doi.org\/10.2214\/AJR.15.15318 .","journal-title":"Am J Roentgenol"},{"key":"804_CR38","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.2214\/AJR.16.17758","volume":"208","author":"N Schieda","year":"2017","unstructured":"\u2022\u2022 Schieda N, Siegelman ES. Update on CT and MRI of adrenal nodules. AJR Am J Roentgenol. 2017;208:1206\u201317. A very useful review on the radiological aspects on adrenal imaging and diagnosing PPGLs. The review gives physicians and radiologists excellent understanding about the appropriate imaging and also how to confidently avoid unnecessary imaging follow-up for cases with adrenal nodules.","journal-title":"AJR Am J Roentgenol"},{"key":"804_CR39","doi-asserted-by":"crossref","first-page":"122","DOI":"10.2214\/AJR.12.9620","volume":"201","author":"J Patel","year":"2013","unstructured":"\u2022 Patel J, Davenport MS, Cohan RH, Caoili EM. Can established CT attenuation and washout criteria for adrenal adenoma accurately exclude pheochromocytoma? AJRAm J Roentgenol. 2013;201:122\u20137. Another review that gives practical imaging diagnostic tips for PPGL diagnosis.","journal-title":"AJRAm J Roentgenol"},{"issue":"2","key":"804_CR40","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1148\/radiology.210.2.r99fe12385","volume":"210","author":"JH Newhouse","year":"1999","unstructured":"Newhouse JH, Heffess CS, Wagner BJ, Imray TJ, Adair CF, Davidson AJ. Large degenerated adrenal adenomas: radiologic-pathologic correlation. Radiology. 1999;210(2):385\u201391. https:\/\/doi.org\/10.1148\/radiology.210.2.r99fe12385 .","journal-title":"Radiology"},{"key":"804_CR41","doi-asserted-by":"crossref","first-page":"302","DOI":"10.2214\/AJR.14.13273","volume":"205","author":"AA Borhani","year":"2015","unstructured":"\u2022 Borhani AA, Hosseinzadeh K. Quantitative versus qualitative methods in evaluation of T2 signal intensity to improve accuracy in diagnosis of pheochromocytoma. AJR Am J Roentgenol. 2015;205:302\u201310. A paper that gives readers idea about MRI features of PPGLs.","journal-title":"AJR Am J Roentgenol"},{"key":"804_CR42","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s12020-015-0544-7","volume":"50","author":"JP Brito","year":"2015","unstructured":"\u2022 Brito JP, Asi N, Gionfriddo MR, et al. The incremental benefit of functional imaging in pheochromocytoma\/paraganglioma: a systematic review. Endocrine. 2015;50:176\u201386. An article that helps readers the need for functional imaging and the utility of that for planning management.","journal-title":"Endocrine"},{"key":"804_CR43","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1007\/s00259-012-2215-8","volume":"39","author":"D Ta\u00efeb","year":"2012","unstructured":"\u2022\u2022 Ta\u00efeb D, Timmers HJ, Hindi\u00e9 E, et al. EANM 2012 guidelines for radionuclide imaging of phaeochromocytoma and paraganglioma. Eur J Nucl Med Mol Imaging. 2012;39:1977\u201395. The most recent European guidelines on functional imaging of PPGLs. Readers are strongly recommended to review this article for better understanding about functional imaging in PPGLs.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"2","key":"804_CR44","first-page":"122","volume":"57","author":"V Rufini","year":"2013","unstructured":"Rufini V, Treglia G, Castaldi P, Perotti G, Giordano A. Comparison of metaiodobenzylguanidine scintigraphy with positron emission tomography in the diagnostic work-up of pheochromocytoma and paraganglioma: a systematic review. Q J Nucl Med Mol Imaging. 2013;57(2):122\u201333.","journal-title":"Q J Nucl Med Mol Imaging"},{"issue":"7","key":"804_CR45","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1007\/s00259-012-2087-y","volume":"39","author":"G Treglia","year":"2012","unstructured":"Treglia G, Cocciolillo F, de Waure C, di Nardo F, Gualano MR, Castaldi P, et al. Diagnostic performance of 18F-dihydroxyphenylalanine positron emission tomography in patients with paraganglioma: a meta-analysis. Eur J Nucl Med Mol Imaging. 2012;39(7):1144\u201353. https:\/\/doi.org\/10.1007\/s00259-012-2087-y .","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"Suppl 1","key":"804_CR46","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1007\/s00259-011-1990-y","volume":"39","author":"M Naji","year":"2012","unstructured":"Naji M, AL-Nahhas A. 68Ga-labelled peptides in the management of neuroectodermal tumours. Eur J Nucl Med Mol Imaging. 2012;39(Suppl 1):S61\u20137.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"4","key":"804_CR47","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/j.surg.2015.03.012","volume":"159","author":"A Imperiale","year":"2016","unstructured":"Imperiale A, Battini S, Averous G, Mutter D, Goichot B, Bachellier P, et al. In vivo detection of catecholamines by magnetic resonance spectroscopy: a potential specific biomarker for the diagnosis of pheochromocytoma. Surgery. 2016;159(4):1231\u20133. https:\/\/doi.org\/10.1016\/j.surg.2015.03.012 .","journal-title":"Surgery"},{"key":"804_CR48","first-page":"1208","volume":"102","author":"B Majtan","year":"2016","unstructured":"Majtan B, Zelinka T, Rosa J, et al. Long-term effect of adrenalectomy on cardiovascular remodeling in patients with pheochromocytoma. J Clin Endocrinol Metab. 2016;102:1208\u201317.","journal-title":"J Clin Endocrinol Metab"},{"key":"804_CR49","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/jch.12571","volume":"17","author":"M Romero","year":"2015","unstructured":"\u2022 Romero M, Kapur G, Baracco R, Valentini RP, Mattoo TK, Jain A. Treatment of hypertension in children with catecholamine-secreting tumors: a systematic approach. J Clin Hypertens (Greenwich). 2015;17:720\u20135. A paper that gives some practical aspects of an approach to paediatric endocrine hypertension.","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"804_CR50","doi-asserted-by":"crossref","first-page":"368","DOI":"10.4158\/EP14036.RA","volume":"21","author":"S-J Galati","year":"2014","unstructured":"Galati S-J, Said M, Gospin R, et al. The mount Sinai clinical pathway for the management of pheochromocytoma. Endocr Pract. 2014;21:368\u201382.","journal-title":"Endocr Pract"},{"issue":"3","key":"804_CR51","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.surg.2015.09.016","volume":"159","author":"T Namekawa","year":"2016","unstructured":"Namekawa T, Utsumi T, Kawamura K, Kamiya N, Imamoto T, Takiguchi T, et al. Clinical predictors of prolonged postresection hypotension after laparoscopic adrenalectomy for pheochromocytoma. Surgery. 2016;159(3):763\u201370. https:\/\/doi.org\/10.1016\/j.surg.2015.09.016 .","journal-title":"Surgery"},{"issue":"4","key":"804_CR52","first-page":"190","volume":"72","author":"PA Zee van der","year":"2014","unstructured":"van der Zee PA, de Boer A. Pheochromocytoma: a review on preoperative treatment with phenoxybenzamine or doxazosin. Neth J Med. 2014;72(4):190\u2013201.","journal-title":"Neth J Med"},{"issue":"12","key":"804_CR53","first-page":"5541","volume":"7","author":"J Li","year":"2014","unstructured":"Li J, Yang CH. Improvement of preoperative management in patients with adrenal pheochromocytoma. Int J Clin Exp Med. 2014;7(12):5541\u20136.","journal-title":"Int J Clin Exp Med"},{"key":"804_CR54","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1245\/s10434-016-5514-7","volume":"24","author":"RW Randle","year":"2017","unstructured":"\u2022 Randle RW, Balentine CJ, Pitt SC, Schneider DF, Sippel RS. Selective versus non-selective \u03b1-blockade prior to laparoscopic adrenalectomy for pheochromocytoma. Ann Surg Oncol. 2017;24:244\u201350. A study detailing the benefits and demerits of the choices of \u03b1-blockers in the preoperative management of PPGLs.","journal-title":"Ann Surg Oncol"},{"key":"804_CR55","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1007\/s00268-017-4095-3","volume":"41","author":"P Heger","year":"2017","unstructured":"\u2022 Heger P, Probst P, H\u00fcttner FJ, et al. Evaluation of open and minimally invasive adrenalectomy: a systematic review and network meta-analysis. World J Surg. 2017;41:2746\u201357. A study that helps in deciding the operative management of PPGLs.","journal-title":"World J Surg"},{"key":"804_CR56","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1007\/s00464-015-4294-7","volume":"30","author":"L Brunaud","year":"2016","unstructured":"\u2022 Brunaud L, Nguyen-Thi P-L, Mirallie E, et al. Predictive factors for postoperative morbidity after laparoscopic adrenalectomy for pheochromocytoma: a multicenter retrospective analysis in 225 patients. Surg Endosc. 2016;30:1051\u20139. Another study helping us to decide the right operative approach to patients with PPGLs.","journal-title":"Surg Endosc"},{"key":"804_CR57","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/cen.12542","volume":"81","author":"N Niemeijer","year":"2014","unstructured":"Niemeijer N, Alblas G, Hulsteijn L, Dekkers O, Corssmit E. Chemotherapy with cyclophosphamide, vincristine and dacarbazine for malignant paraganglioma and pheochromocytoma: systematic review and meta-analysis. Clin Endocrinol(Oxf). 2014;81:642\u201351.","journal-title":"Clin Endocrinol(Oxf)"},{"issue":"10","key":"804_CR58","doi-asserted-by":"publisher","first-page":"4006","DOI":"10.1210\/jc.2013-1907","volume":"98","author":"S Hescot","year":"2013","unstructured":"Hescot S, Leboulleux S, Amar L, Vezzosi D, Borget I, Bournaud-Salinas C, et al. One-year progression-free survival of therapy-naive patients with malignant pheochromocytoma and paraganglioma. J Clin Endocrinol Metab. 2013;98(10):4006\u201312. https:\/\/doi.org\/10.1210\/jc.2013-1907 .","journal-title":"J Clin Endocrinol Metab"},{"key":"804_CR59","doi-asserted-by":"crossref","first-page":"6162","DOI":"10.1002\/cncr.27675","volume":"118","author":"O DY","year":"2012","unstructured":"DY O, Kim TW, Park S, et al. Phase 2 study of everolimus monotherapy in patients with nonfunctioning neuroendocrine tumors or pheochromocytomas-paragangliomas. Cancer. 2012;118:6162\u201370.","journal-title":"Cancer"},{"issue":"2","key":"804_CR60","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.canlet.2014.07.005","volume":"352","author":"M Denorme","year":"2014","unstructured":"Denorme M, Yon L, Roux C, Gonzalez BJ, Baudin E, Anouar Y, et al. Both sunitinib and sorafenib are effective treatments for pheochromocytoma in a xenograft model. Cancer Lett. 2014;352(2):236\u201344. https:\/\/doi.org\/10.1016\/j.canlet.2014.07.005 .","journal-title":"Cancer Lett"},{"key":"804_CR61","doi-asserted-by":"crossref","unstructured":"Chen W, Hill H, Christie A, et al. Targeting renal cell carcinoma with a HIF-2 antagonist. Nature 2016;539112\u20137.","DOI":"10.1038\/nature19796"},{"issue":"11","key":"804_CR62","doi-asserted-by":"publisher","first-page":"2711","DOI":"10.1002\/ijc.28913","volume":"135","author":"J Hadoux","year":"2014","unstructured":"Hadoux J, Favier J, Scoazec JY, Leboulleux S, al Ghuzlan A, Caramella C, et al. SDHB mutations are associated with response to temozolomide in patients with metastatic pheochromocytoma or paraganglioma. Int J Cancer. 2014;135(11):2711\u201320. https:\/\/doi.org\/10.1002\/ijc.28913 .","journal-title":"Int J Cancer"},{"key":"804_CR63","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1053\/j.semnuclmed.2016.01.011","volume":"46","author":"JA Carrasquillo","year":"2016","unstructured":"Carrasquillo JA, Pandit-Taskar N, Chen CC. I-131 metaiodobenzylguanidine therapy of pheochromocytoma and paraganglioma. Semin Nucl Med. 2016;46:203\u201314.","journal-title":"Semin Nucl Med"},{"key":"804_CR64","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1093\/qjmed\/hcu208","volume":"108","author":"MA Rutherford","year":"2015","unstructured":"\u2022 Rutherford MA, Rankin AJ, Yates TM, Mark PB, Perry CG, Reed NS, et al. Management of metastatic phaeochromocytoma and paraganglioma: use of iodine-131-meta-iodobenzylguanidine therapy in a tertiary referral centre. QJM. 2015;108:361\u20138. A useful paper for readers to consider the benefit of radiopharmaceuticals in malignant PPGLs.","journal-title":"QJM"},{"issue":"12","key":"804_CR65","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1507\/endocrj.EJ14-0211","volume":"61","author":"K Yoshinaga","year":"2014","unstructured":"Yoshinaga K, Oriuchi N, Wakabayashi H, Tomiyama Y, Jinguji M, Higuchi T, et al. Effects and safety of 131I-metaiodobenzylguanidine (MIBG) radiotherapy in malignant neuroendocrine tumors: results from a multicenter observational registry. Endocr J. 2014;61(12):1171\u201380. https:\/\/doi.org\/10.1507\/endocrj.EJ14-0211 .","journal-title":"Endocr J"},{"key":"804_CR66","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/jso.24553","volume":"115","author":"K Nastos","year":"2017","unstructured":"Nastos K, Cheung VTF, Toumpanakis C, Navalkissoor S, Quigley AM, Caplin M, et al. Peptide receptor radionuclide treatment and (131)I-MIBG in the management of patients with metastatic\/progressive phaeochromocytomas and paragangliomas. J Surg Oncol. 2017;115:425\u201334.","journal-title":"J Surg Oncol"},{"key":"804_CR67","doi-asserted-by":"crossref","first-page":"e457","DOI":"10.1097\/RLU.0000000000001816","volume":"42","author":"S Ballal","year":"2017","unstructured":"\u2022 Ballal S, Yadav MP, Damle NA, Sahoo RK, Bal C. Concomitant 177Lu-DOTATATE and capecitabine therapy in patients with advanced neuroendocrine tumors: a long-term-outcome, toxicity, survival, and quality-of-life study. Clin Nucl Med. 2017;42:e457\u201366. A paper that gives details of modern radionuclide therapy in PPGLs.","journal-title":"Clin Nucl Med"},{"issue":"5","key":"804_CR68","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1055\/s-0032-1308992","volume":"44","author":"L Fishbein","year":"2012","unstructured":"Fishbein L, Bonner L, Torigian DA, Nathanson KL, Cohen DL, Pryma D, et al. External beam radiation therapy (EBRT) for patients with malignant pheochromocytoma and non-head and -neck paraganglioma: combination with 131IMIBG. Horm Metab Res. 2012;44(5):405\u201310. https:\/\/doi.org\/10.1055\/s-0032-1308992 .","journal-title":"Horm Metab Res"},{"key":"804_CR69","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.jvir.2011.06.016","volume":"22","author":"JF McBride","year":"2011","unstructured":"McBride JF, Atwell TD, Charboneau WJ, Young WF Jr, Wass TC, Callstrom MR. Minimally invasive treatment of metastatic pheochromocytoma and paraganglioma: efficacy and safety of radiofrequencyablation and cryoablation therapy. J Vasc Interv Radiol. 2011;22:1263\u201370.","journal-title":"J Vasc Interv Radiol"},{"key":"804_CR70","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1007\/s00270-011-0137-7","volume":"34","author":"P Kumar","year":"2011","unstructured":"Kumar P, Bryant T, Breen D, Stedman B, Hacking N. Transarterial embolization and doxorubicin eluting beads-transarterial chemoembolization (DEB-TACE) of malignant extra-adrenal pheochromocytoma. Cardiovasc Intervent Radiol. 2011;34:1325\u20139.","journal-title":"Cardiovasc Intervent Radiol"},{"key":"804_CR71","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.maturitas.2013.12.009","volume":"77","author":"A Tsirlin","year":"2014","unstructured":"\u2022\u2022 Tsirlin A, Oo Y, Sharma R, Kansara A, Gliwa A, Banerji MA. Pheochromocytoma: a review. Maturitas. 2014;77:229\u201338. A very useful review article that gives detailed literature on PPGLs. Readers are recommended to read this excellent paper.","journal-title":"Maturitas"},{"key":"804_CR72","doi-asserted-by":"crossref","first-page":"R135","DOI":"10.1530\/EJE-16-0189","volume":"175","author":"L Amar","year":"2016","unstructured":"\u2022\u2022 Amar L, Lussey-Lepoutre C, Lenders JW, Djadi-Prat J, Plouin PF, Steichen O. MANAGEMENT OF ENDOCRINE DISEASE: recurrence or new tumors after complete resection of pheochromocytomas and paragangliomas: a systematic review and meta-analysis. Eur J Endocrinol. 2016;175:R135\u201345. A recent article to help readers to understand the management aspects of recurrent PPGLs.","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"804_CR73","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1196\/annals.1353.003","volume":"1073","author":"M Barontini","year":"2006","unstructured":"Barontini M, Levin G, Sanso G. Characteristics of pheochromocytoma in a 4- to 20-year-old population. Ann N Y Acad Sci. 2006;1073(1):30\u20137. https:\/\/doi.org\/10.1196\/annals.1353.003 .","journal-title":"Ann N Y Acad Sci"},{"key":"804_CR74","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1210\/jc.2016-3829","volume":"102","author":"C Pamporaki","year":"2017","unstructured":"\u2022\u2022 Pamporaki C, Hamplova B, Peitzsch M, et al. Characteristics of pediatric vs adult pheochromocytomas and paragangliomas. J Clin Endocrinol Metab. 2017;102:1122\u201332. An excellent review to update readers about age-specific clinical characteristics of PPGLs.","journal-title":"J Clin Endocrinol Metab"},{"key":"804_CR75","doi-asserted-by":"crossref","first-page":"300","DOI":"10.4158\/EP09191.RA","volume":"16","author":"V Sarathi","year":"2010","unstructured":"Sarathi V, Lila AR, Bandgar TR, Menon PS, Shah NS. Pheochromocytoma and pregnancy: a rare but dangerous combination. Endocr Pract. 2010;16:300\u20139.","journal-title":"Endocr Pract"},{"key":"804_CR76","doi-asserted-by":"crossref","first-page":"R49","DOI":"10.1530\/EJE-16-0920","volume":"177","author":"K Weerd van der","year":"2017","unstructured":"\u2022\u2022 van der Weerd K, van Noord C, Loeve M, et al. ENDOCRINOLOGY IN PREGNANCY: pheochromocytoma in pregnancy: case series and review of literature. Eur J Endocrinol. 2017;177:R49\u201358. An excellent review to update readers about the practical aspects of care of patients with PPGLs during pregnancy.","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"804_CR77","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1002\/bjs.8976","volume":"100","author":"MA Biggar","year":"2013","unstructured":"Biggar MA, Lennard TW. Systematic review of phaeochromocytoma in pregnancy. Br J Surg. 2013;100(2):182\u201390. https:\/\/doi.org\/10.1002\/bjs.8976 .","journal-title":"Br J Surg"},{"key":"804_CR78","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1590\/S1677-5538.IBJU.2015.0503","volume":"42","author":"V Srougi","year":"2016","unstructured":"\u2022 Srougi V, Chambo JL, Tanno FY, et al. Presentation and surgery outcomes in elderly with pheocromocytoma: a comparative analysis with Young patients. Int Braz J Urol. 2016;42:671\u20137. A useful paper to understand the difference in surgical outcomes in patients of different ages, old vs. young, with PPGLs.","journal-title":"Int Braz J Urol"}],"container-title":["Current Hypertension Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11906-018-0804-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-018-0804-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-018-0804-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,25]],"date-time":"2020-10-25T22:56:35Z","timestamp":1603666595000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11906-018-0804-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":78,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["804"],"URL":"https:\/\/doi.org\/10.1007\/s11906-018-0804-z","relation":{},"ISSN":["1522-6417","1534-3111"],"issn-type":[{"value":"1522-6417","type":"print"},{"value":"1534-3111","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1]]},"article-number":"3"}}